Delica Medical

Shenzhen, Guangdong, ChinaFounded 199851–100 employeesdelicasz.comLinkedIn

Brain-computer interfaces
Neuromodulation
EEG and neural monitoring

深圳德力凯医疗电子股份有限公司, founded in 1998, is a Chinese medical technology company focused on non-invasive brain-computer interface and neurodiagnostic solutions. It develops integrated technologies spanning EEG, AI-assisted analysis, transcranial magnetic stimulation, ultrasound neuromodulation, vascular ultrasound, brain oxygen monitoring, and neurocritical care for hospitals and home-based health applications.

Visit delicasz.com ↗

Founded: 1998
Employees: 51–100

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Delica Medical’s available milestone history is concentrated in its earlier corporate and financing events rather than dated announcements from the past several years. The company raised CNY 1.6 million, equivalent to approximately $258,557, in an angel round led by GAEA Capital on Jul 28, 2015. It subsequently became publicly traded on the National Equities Exchange and Quotations under stock symbol 837573 on May 26, 2016. Its current product and technology profile spans transcranial Doppler, vascular ultrasound, EEG, brain oxygen monitoring, intracranial pressure assessment, transcranial magnetic stimulation, and AI-assisted analysis. The company states that its products serve more than 800 tertiary hospitals in China and reach nearly 30 countries and regions. It also identifies National High-Tech Enterprise and specialized, innovative Little Giant Enterprise recognition, alongside ISO 13485 quality certifications and CE and FDA certifications for multiple product lines.

Market position

Delica Medical operates at the intersection of neurodiagnostics, vascular imaging, neuromodulation, and medical-device manufacturing. Its portfolio is broader than a single-modality diagnostics company: it includes digital and ambulatory EEG, transcranial Doppler, multifunctional vascular ultrasound, hemodynamics systems, brain oxygen monitoring, and non-invasive intracranial-pressure assessment. The website positioning further extends into brain-computer interface applications, AI-assisted EEG interpretation, AI-based cerebral blood-flow analysis, transcranial magnetic stimulation, and closed-loop ultrasound neuromodulation. This combination gives Delica Medical a potential differentiation based on integrating signal acquisition, analysis, and intervention within one clinical technology platform. However, the available company record does not provide a verified competitor set, comparative revenue data, market-share figures, or head-to-head clinical evidence. It therefore supports a capability-based positioning assessment rather than a definitive ranking against named competitors. Its stated deployment across more than 800 tertiary hospitals and exports to nearly 30 countries indicate established institutional reach, while ISO 13485, CE, and FDA-related product credentials support participation in regulated healthcare markets.

Growth & opportunities

Delica Medical’s trajectory reflects a transition from a Shenzhen medical-equipment manufacturer founded in 1998 to a broader neurotechnology and clinical diagnostics platform. The clearest financial inflection point was the CNY 1.6 million angel round led by GAEA Capital on Jul 28, 2015, followed by an NEEQ listing on May 26, 2016 under symbol 837573. The company’s product scope has expanded beyond conventional ultrasound and EEG into brain oxygen monitoring, non-invasive intracranial-pressure analysis, transcranial magnetic stimulation, closed-loop neuromodulation, and AI-supported interpretation. Its stated reach of more than 800 tertiary hospitals in China and nearly 30 international markets suggests that commercialization has progressed alongside technology development.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Delica Medical distinct

reccy insights

What makes Delica Medical distinct

01Recognized as a leading Chinese clinical non-invasive brain-computer interface platform company.
02Provides an end-to-end platform covering brain-signal acquisition, AI-powered analysis, and non-invasive neuromodulation.
03Serves more than 800 tertiary hospitals across China and exports products to nearly 30 countries and regions.
04Holds National High-Tech Enterprise and specialized, innovative Little Giant Enterprise recognition.
05Maintains ISO 13485 quality certifications through TÜV Rheinland and SGS, with multiple product lines holding CE and FDA certifications.

Technology & products6

Technology & products

Transcranial Doppler (TCD) Series
Devices that use ultrasound to measure cerebral blood flow velocity through the skull non-invasively.
Vascular Ultrasound Series
Ultrasound equipment for imaging and assessing blood vessels in the head and neck region.
Neuroelectrophysiology Series
Equipment for recording and analyzing electrical activity of the nervous system, including EEG and evoked potentials.
Hemodynamics Series
Systems designed to monitor and analyze blood flow dynamics and related physiological parameters.
Non-invasive Brain Oxygenation Monitor
A device that measures brain oxygen levels without invasive procedures.
Non-invasive Intracranial Pressure Detection and Analysis Device
Equipment that estimates intracranial pressure without invasive methods.

Show all 6 products

+ 3 more: Hemodynamics Series, Non-invasive Brain Oxygenation Monitor, Non-invasive Intracranial Pressure Detection and Analysis Device

Recent updates2

Launches, partnerships and team changes from press coverage

Award
National High-Tech Enterprise
Award
Specialized, Innovative Little Giant Enterprise

Similar companies

Show all 6 companies

About Delica Medical

Products: Transcranial Doppler (TCD) Series, Vascular Ultrasound Series, Neuroelectrophysiology Series, Hemodynamics Series, Non-invasive Brain Oxygenation Monitor, Non-invasive Intracranial Pressure Detection and Analysis Device
Focus areas: NeuroTechnology, medical devices, diagnostics, AI/ML, medical devices, BCI, neurotechnology, EEG
Headquarters: Shenzhen, Guangdong, China
Founded: 1998
Employees: 51–100
Patents granted: 17 (Crunchbase)
Trademarks: 4